33 results on '"Burt, Alastair"'
Search Results
2. A prospective observational study of the effect of critical illness on ultrastructural and microscopic morphology of duodenal mucosa
3. TOP-289 Artificial intelligence-based measurement of non-alcoholic steatohepatitis is an accurate tool for clinical trial enrollment and end point assessment
4. SAT-426 - AI-enabled virtual hematoxylin and eosin and Masson’s trichrome staining for non-alcoholic fatty liver disease activity scoring from single unstained slide
5. Corrigendum to: “Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆” [J Hepatol (2020) 505–515]
6. An End-to-End Platform for Digital Pathology Using Hyperspectral Autofluorescence Microscopy and Deep Learning-Based Virtual Histology.
7. Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture
8. Computer-aided diagnosis for characterization of colorectal lesions: comprehensive software that includes differentiation of serrated lesions.
9. Deficient repair of DNA lesion O6-methylguanine in cirrhosis
10. Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic category.
11. Liver cell dysplasia and early hepatocellular carcinoma.
12. Pathology of liver transplantation.
13. Pathology of liver tumours.
14. Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease.
15. Investigation of a Mechanism for Accelerated Breakdown of Immune Tolerance to the Primary Biliary Cirrhosis-Associated Autoantigen, Pyruvate Dehydrogenase Complex.
16. Narrow-band imaging for scar (NBI-SCAR) classification: from conception to multicenter validation.
17. Well-differentiated hepatocellular neoplasm of uncertain malignant potential-reply.
18. Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial.
19. Methylprednisolone does not inhibit the nonparenchymal cell responses to dimethylnitrosamine-induced liver injury
20. Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury
21. In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion
22. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis
23. Characterisation of the DNA repair enzyme for O6-methylguanine in cirrhosis
24. Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease.
25. Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.
26. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆.
27. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management.
28. Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505–515).
29. AS159 - A transcriptomic signature predicting fibrosis progression in a large European cohort of patients with histologically characterised NAFLD.
30. The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease.
31. Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser.
32. Deep learning uncertainty and confidence calibration for the five-class polyp classification from colonoscopy.
33. Chronic elevated systemic glucocorticoid results in widespread pancreatic–hepatic trans-differentiation in vivo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.